Kidney Transplantation from Thin Basement Membrane Nephropathy Donor.
1Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
2Laboratory Medicine, Korea Organ Donation Agency, Seoul, Republic of Korea
3Surgery, Myongji Hospital, Goyang, Gyeonggi-do, Republic of Korea.
Meeting: 2016 American Transplant Congress
Abstract number: C170
Keywords: Donors, Kidney transplantation, marginal, Nephropathy
Session Information
Session Name: Poster Session C: Kidney Donor Evaluation and Donor Nephrectomy
Session Type: Poster Session
Date: Monday, June 13, 2016
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Halls C&D
Purpose
Thin basement membrane nephropathy (TBMN) is the most common cause of persistent glomerular hematuria. Most individuals with TBMN shows benign course, but it is hard to distinguish from what is secondary change of progressive renal diseases. Therefore, when the graft kidney appears TBMN in kidney transplantation, it is important to both recipient and donor. However, there are few studies addressing the prognosis of donor and recipient from TBMN kidney donor.
Methods
From 2007 to 2014, 10 recipients have received kidney graft from donor who was diagnosed to have thinner basement membrane than 250 nm at pre-transplant donor biopsy. The data has been collected in the transplant center database and was analyzed with continuing data accumulation.
Results
The recipients were 37.1 ± 17.4 years of age, they were followed up for 1351 ± 851.4 (range, 132 – 2932) days after the transplantation. Their creatinine level was dramatically decreased (p<0.001) from pre-transplantation (9.62 ± 3.94) to post-transplantation 7th day (1.66 ± 1.31), but there was no significant change after then (p=0.547). One implanted kidney showed thin glomerular basement membrane (GBM, 150 – 250 [mu]m) on 0 day biopsy, and two appeared thin GBM at 10th day protocol biopsy. Others showed normal GBM thickness on the protocol biopsy. Four patients appeared acute T cell medicated rejection and one patient showed borderline change at 10th day protocol biopsy. One patient who appeared normal GBM at 0 day biopsy underwent graft failure postoperative 2nd day due to graft arterial occlusion. The donors were 45.9 ± 9.7 years of age, and they were followed up for 855 ± 963.5 (range, 15 – 2904) days after the transplantation. Donor creatinine was increased significantly at postoperative 7th days compared to pre-transplantation (from 0.73 ± 0.12 to 1.08 ± 0.22, p<0.001), but there is no one has been over 1.5 mg/dL and no significant change during the follow-up period (p=0.612).
Conclusion
There is no evidence for decreasing kidney function in the recipient after kidney transplantation from TBMN donor. And it is appeared that the TMMN donor is also safe after kidney donation. However, it is needs to follow up the donor as well as the recipient for longer time.
CITATION INFORMATION: Choi C, Han A, Kim S.-Y, Cho S, Cho M.-J, Lee C, Ahn S, Min S.-K, Ha J, Park M, Kim S, Jung I, Min S.-I. Kidney Transplantation from Thin Basement Membrane Nephropathy Donor. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:
Choi C, Han A, Kim S-Y, Cho S, Cho M-J, Lee C, Ahn S, Min S-K, Ha J, Park M, Kim S, Jung I, Min S-I. Kidney Transplantation from Thin Basement Membrane Nephropathy Donor. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/kidney-transplantation-from-thin-basement-membrane-nephropathy-donor/. Accessed November 22, 2024.« Back to 2016 American Transplant Congress